Tan S E, Wenthold R J, Soderling T R
Vollum Institute, Oregon Health Sciences University, Portland 97201.
J Neurosci. 1994 Mar;14(3 Pt 1):1123-9. doi: 10.1523/JNEUROSCI.14-03-01123.1994.
Phosphorylation of glutamate receptors (GluRs) is emerging as an important regulatory mechanism. In this study 32P labeling of non-NMDA GluRs was investigated in cultured hippocampal neurons stimulated 2-15 min with agonists that selectively stimulate either Ca2+/calmodulin-dependent protein kinase II (CaM-kinase II), Ca2+/phospholipid-dependent protein kinase C (PKC), or cAMP-dependent protein kinase A (PKA). Treatment of hippocampal neurons with glutamate/glycine (Glu/Gly), ionomycin, or 12-O-tetradecanoylphorbol 13-acetate (TPA) increased 32P labeling of immunoprecipitated alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA)-type GluRs by 145%, 180%, and 227%, respectively, of control values. This increased phosphorylation of GluRs was predominantly 32P-Ser with little 32P-Thr and no detectable 32P-Tyr. Glu/Gly and ionomycin, but not TPA, also increased 32P labeling of CaM-kinase II by 175% and 195%, respectively, of control values. Of these three agonists, only TPA stimulated phosphorylation of MARCKS (225% of control), a specific substrate of PKC. Forskolin treatment gave a three- to fourfold increase in the active catalytic subunit of PKA but did not result in the 32P labeling of AMPA-type GluRs, CaM-kinase II, or MARCKS. Phosphorylation of GluRs in response to Glu/Gly was blocked by a specific NMDA receptor/ion channel antagonist (DL-2-amino-5-phosphonovaleric acid) or by a cell-permeable inhibitor of CaM-kinase II (1-[N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine, KN-62). These results are consistent with the hypothesis that Ca2+ influx through the NMDA-type ion channel can activate CaM-kinase II, which in turn can phosphorylate and regulate AMPA-type GluR ion channels (McGlade-McCulloh et al., 1993).(ABSTRACT TRUNCATED AT 250 WORDS)
谷氨酸受体(GluRs)的磷酸化正逐渐成为一种重要的调节机制。在本研究中,对培养的海马神经元中32P标记的非NMDA型谷氨酸受体进行了研究,这些神经元用能选择性刺激钙/钙调蛋白依赖性蛋白激酶II(CaM-激酶II)、钙/磷脂依赖性蛋白激酶C(PKC)或环磷酸腺苷依赖性蛋白激酶A(PKA)的激动剂刺激2至15分钟。用谷氨酸/甘氨酸(Glu/Gly)、离子霉素或12-O-十四烷酰佛波醇-13-乙酸酯(TPA)处理海马神经元,使免疫沉淀的α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)型谷氨酸受体的32P标记分别增加至对照值的145%、180%和227%。谷氨酸受体这种增加的磷酸化主要是32P-丝氨酸,32P-苏氨酸很少,且未检测到32P-酪氨酸。Glu/Gly和离子霉素,而非TPA,也使CaM-激酶II的32P标记分别增加至对照值的175%和195%。在这三种激动剂中,只有TPA刺激了PKC的特异性底物MARCKS的磷酸化(为对照值的225%)。福斯可林处理使PKA的活性催化亚基增加了三到四倍,但未导致AMPA型谷氨酸受体、CaM-激酶II或MARCKS的32P标记。对Glu/Gly作出反应时谷氨酸受体的磷酸化被一种特异性NMDA受体/离子通道拮抗剂(DL-2-氨基-5-磷酸缬氨酸)或一种可透过细胞的CaM-激酶II抑制剂(1-[N,O-双(1,5-异喹啉磺酰基)-N-甲基-L-酪氨酰]-4-苯基哌嗪,KN-62)所阻断。这些结果与以下假说一致:通过NMDA型离子通道的Ca2+内流可激活CaM-激酶II,而CaM-激酶II继而可使AMPA型谷氨酸受体离子通道磷酸化并对其进行调节(McGlade-McCulloh等人,1993年)。(摘要截短于250字)